fbpx
November 6, 2022

Chinese Herbal Medicine May Offer Benefits in STEMI: CTS-AMI Chinese Herbal Medicine May Offer Benefits in STEMI: CTS-AMI

The traditional Chinese herbal medicine tongxinluo added to guideline-directed therapy improves clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI), the CTS-AMI study suggests. Compared […]
November 6, 2022

Avoid Routine Early ECMO in Severe Cardiogenic Shock: ECMO-CS Avoid Routine Early ECMO in Severe Cardiogenic Shock: ECMO-CS

Routine early, expeditious use of extracorporeal membrane oxygenation (ECMO) is a common strategy in patients with severe cardiogenic shock, but a less aggressive initial approach may […]
November 5, 2022

CRISPR Gene Editing Takes Next Step in TTR Amyloidosis CRISPR Gene Editing Takes Next Step in TTR Amyloidosis

Treatment with the investigational CRISPR-Cas9 gene-editing therapy, NTLA-2001, led to rapid responses in patients with transthyretin (TTR) amyloidosis with cardiomyopathy (ATTR-CM), interim phase 1 results show. […]
November 5, 2022

No Survival Gain for Torsemide vs Furosemide in HF: TRANSFORM-HF No Survival Gain for Torsemide vs Furosemide in HF: TRANSFORM-HF

The choice of loop diuretic for decongestion in patients hospitalized with heart failure (HF) may make little difference to survival or readmission risk over the next […]
November 5, 2022

Triglyceride Lowering Fails to Show CV Benefit in Large Fibrate Trial Triglyceride Lowering Fails to Show CV Benefit in Large Fibrate Trial

Despite a 25% reduction in triglycerides (TGs) along with similar reductions in very-low-density lipoprotein (VLDL), and remnant cholesterol, a novel agent failed to provide any protection […]
November 5, 2022

Diuretic Agents Equal to Prevent CV Events in Hypertension: DCP Diuretic Agents Equal to Prevent CV Events in Hypertension: DCP

There was no difference in major cardiovascular outcomes with the use of two different diuretics — chlorthalidone or hydrochlorothiazide — in the treatment of hypertension in […]
November 5, 2022

Study Sheds New Light on RAS Inhibitors’ Role for Advanced CKD Study Sheds New Light on RAS Inhibitors’ Role for Advanced CKD

ORLANDO, Florida — Treatment with a renin-angiotensin system (RAS) inhibitor is widely accepted as standard practice for slowing progression of chronic kidney disease (CKD), but data […]
November 5, 2022

CDC Warns of Early Uptick in Respiratory Disease CDC Warns of Early Uptick in Respiratory Disease

The Centers for Disease Control and Prevention is warning of an early surge in respiratory disease caused by multiple viruses. As influenza viruses, respiratory syncytial virus […]
November 5, 2022

Surgical Site Dressing Turns Blue When It Needs Changing Surgical Site Dressing Turns Blue When It Needs Changing

Surgical site infections are one of the top causes of postoperative morbidity and death worldwide, but there is little agreement and much debate over the most […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792793794795796797798799800801802803804
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0